More Musical Chairs For Device Center’s Higher-Ups

During the final months under former FDA Commissioner Andrew von Eschenbach's leadership, the device center continued to tinker with its upper management, with more than 30 staffers either changing roles or leaving the agency since August (see chart: "1CDRH In Flux").

More from Archive

More from Medtech Insight